Revelation Biosciences Revenue and Competitors

Location

$22.3M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Revelation Biosciences's estimated annual revenue is currently $1.4M per year.(i)
  • Revelation Biosciences's estimated revenue per employee is $77,500
  • Revelation Biosciences's total funding is $22.3M.

Employee Data

  • Revelation Biosciences has 18 Employees.(i)
  • Revelation Biosciences grew their employee count by 20% last year.

Revelation Biosciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Director and CEOReveal Email/Phone
3
ControllerReveal Email/Phone
4
VP Human Resources & Investor RelationsReveal Email/Phone
5
Director FinanceReveal Email/Phone
6
Chief Financial OfficerReveal Email/Phone
7
Senior Research Associate-BioanalyticalReveal Email/Phone
8
Accounting ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Revelation Biosciences?

We develop immunologic therapeutics and diagnostics designed to make the world a healthier place

keywords:N/A

$22.3M

Total Funding

18

Number of Employees

$1.4M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Revelation Biosciences News

2022-04-17 - Revelation Biosciences Inc (REVB) Down 7.03% in Premarket Trading

Revelation Biosciences Inc (REVB) has fallen Friday morning, with the stock declining -7.03% in pre-market trading to 1.19.

2022-04-06 - Revelation Biosciences Inc. Announces Conference Call to ...

(NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic?based...

2022-03-30 - Revelation Biosciences Inc. Announces Primary Endpoint ...

Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.6M18-31%$108.5M
#2
$0.7M18260%N/A
#3
$0.7M1820%$7M
#4
$2.3M1820%$8M
#5
$2.9M180%N/A